Concepedia

Rowan Stringer

RS

Statistics

Publications

29

Citations

1.6K

H-Index

22

Active since

1986

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (United Kingdom)

Novartis (United States)

Genomics Institute of the Novartis Research Foundation

Rowan Stringer is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1986–2023

29

Publications

29

A Novel Murine Model of Severe Pulmonary Arterial Hypertension

Loredana Ciuclan, Olivier Bonneau, Martin Hussey et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 246 citations

Prediction of Drug Clearance by Glucuronidation from in Vitro Data: Use of Combined Cytochrome P450 and UDP-Glucuronosyltransferase Cofactors in Alamethicin-Activated Human Liver Microsomes

Peter Kilford, Rowan Stringer, Bindi Sohal et al. · Drug Metabolism and Disposition · 2008 · 186 citations

Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C

Andreas Weiss, Edwige Lorthiois, Louise Barys et al. · Cancer Discovery · 2022 · 130 citations · Full text

Reliability of human cryopreserved hepatocytes and liver microsomes as<b><i>in vitro</i></b>systems to predict metabolic clearance

Rowan Stringer, Paul Nicklin, J. Brian Houston · Xenobiotica · 2008 · 84 citations

, , +23

JDQ443, a Structurally Novel, Pyrazole-Based, Covalent Inhibitor of KRAS<sup>G12C</sup> for the Treatment of Solid Tumors

Edwige Lorthiois, Marc Gerspacher, Kim S. Beyer et al. · Journal of Medicinal Chemistry · 2022 · 84 citations · Full text

Rows per page

1–5 of 29